Godrej Consumer (GCPL) is one of our top pick from our Staples Coverage Universe over a one-year horizon. We present here our investment rationale: Increasing traction in the domestic business should improve margins and return ratios. The focus on profitability improvement in the African region (GCPL’s second largest sales contributor) and continued discipline in capital allocation will reduce the historical drag on the overseas businesses. Among staples, GCPL is the key beneficiary of the recent reduction in material costs. Palm oil prices have come off significantly, and even if a reasonable share of this gain is spent on advertising, it will boost Ebitda growth from Q4FY23 onward. While the company’s target of achieving sustainable double-digit sales growth in household insecticides (HI) could be delayed, its other domestic segments are showing signs of promising traction.
Also read: Digital and tech ‘propel’ Retail and FMCG sectors to reinvent in the new normal: Deloitte-FICCI Report
GCPL’s domestic businesses had demonstrated strong sales growth in the first half of the last decade, before losing steam in the second half. Domestic and consolidated sales growth crossed double digits in the last two years and appears to do so in FY23 as well. We expect GCPL to be the key beneficiary of the sharp reduction in raw material costs over the next few quarters.